Similarly, other studies using a scFv to GPA33 fused with WT α-sarcin containing a G4S linker effectively killed cells and demonstrated anti-tumour effects in vivo (Carreras-Sangrà et al., 2012; Tomé-Amat et al., 2015a). This evidence concerns the gene GPA33 and neoplasm.